259 related articles for article (PubMed ID: 34880079)
21. Molecular characteristics of colorectal neuroendocrine carcinoma; similarities with adenocarcinoma rather than neuroendocrine tumor.
Takizawa N; Ohishi Y; Hirahashi M; Takahashi S; Nakamura K; Tanaka M; Oki E; Takayanagi R; Oda Y
Hum Pathol; 2015 Dec; 46(12):1890-900. PubMed ID: 26434631
[TBL] [Abstract][Full Text] [Related]
22. Neuroendocrine Carcinomas of the Uterine Cervix, Endometrium, and Ovary Show Higher Tendencies for Bone, Brain, and Liver Organotrophic Metastases.
Park HK
Curr Oncol; 2022 Oct; 29(10):7461-7469. PubMed ID: 36290864
[TBL] [Abstract][Full Text] [Related]
23. Comprehensive analysis of clinicopathologic features and p53 mutation in neuroendocrine neoplasms of the breast: experience from a large academic center.
Shafi S; Hu Y; Parwani AV; Ding Q; Li Z
Breast Cancer Res Treat; 2022 Dec; 196(3):463-469. PubMed ID: 36260193
[TBL] [Abstract][Full Text] [Related]
24. Mixed Neuroendocrine/Non-neuroendocrine Neoplasm (MiNEN) of the Ovary Arising from Endometriosis: Molecular Pathology Analysis in Support of a Pathogenetic Paradigm.
Maragliano R; Libera L; Carnevali I; Pensotti V; De Vecchi G; Testa M; Amaglio C; Leoni E; Formenti G; Sessa F; Furlan D; Uccella S
Endocr Pathol; 2022 Sep; 33(3):400-410. PubMed ID: 34342838
[TBL] [Abstract][Full Text] [Related]
25. [Neuroendocrine neoplasms : Two families with distinct features unified in one classification (German version)].
Klöppel G
Pathologe; 2019 May; 40(3):211-219. PubMed ID: 30969346
[TBL] [Abstract][Full Text] [Related]
26. Comprehensive genomic and transcriptomic characterization of high-grade gastro-entero-pancreatic neoplasms.
Angerilli V; Sabella G; Simbolo M; Lagano V; Centonze G; Gentili M; Mangogna A; Coppa J; Munari G; Businello G; Borga C; Schiavi F; Pusceddu S; Leporati R; Oldani S; Fassan M; Milione M
Br J Cancer; 2024 May; ():. PubMed ID: 38729995
[TBL] [Abstract][Full Text] [Related]
27. Incidence and prevalence of neuroendocrine neoplasms in Norway 1993-2021.
Thiis-Evensen E; Boyar Cetinkaya R
J Neuroendocrinol; 2023 Apr; 35(4):e13264. PubMed ID: 36988112
[TBL] [Abstract][Full Text] [Related]
28. Comparative study of lung and extrapulmonary poorly differentiated neuroendocrine carcinomas: A SEER database analysis of 162,983 cases.
Dasari A; Mehta K; Byers LA; Sorbye H; Yao JC
Cancer; 2018 Feb; 124(4):807-815. PubMed ID: 29211313
[TBL] [Abstract][Full Text] [Related]
29. Molecular profiling of gastric neuroendocrine carcinomas.
Ikegame K; Hatakeyama K; Terashima M; Sugino T; Aizawa D; Furukawa K; Fujiya K; Tanizawa Y; Bando E; Yamaguchi K
Eur J Surg Oncol; 2023 Sep; 49(9):106987. PubMed ID: 37463826
[TBL] [Abstract][Full Text] [Related]
30. SATB2 in neuroendocrine neoplasms: strong expression is restricted to well-differentiated tumours of lower gastrointestinal tract origin and is most frequent in Merkel cell carcinoma among poorly differentiated carcinomas.
Bellizzi AM
Histopathology; 2020 Jan; 76(2):251-264. PubMed ID: 31233624
[TBL] [Abstract][Full Text] [Related]
31. Survivals of patients with pancreatic neuroendocrine carcinomas: An in-depth analysis by the American Joint Committee on Cancer 8th tumor-node-metastasis staging manual.
Deng BY; Yang M; Wen JY; Hou SZ; Chen Y; Tian BL; Liu XB; Zhang Y
Medicine (Baltimore); 2020 Jan; 99(3):e18736. PubMed ID: 32011453
[TBL] [Abstract][Full Text] [Related]
32. Molecular Classification of Extrapulmonary Neuroendocrine Carcinomas With Emphasis on POU2F3-positive Tuft Cell Carcinoma.
Koh J; Kim H; Moon KC; Lee C; Lee K; Ryu HS; Jung KC; Jeon YK
Am J Surg Pathol; 2023 Feb; 47(2):183-193. PubMed ID: 36253891
[TBL] [Abstract][Full Text] [Related]
33. A Practical Approach to the Classification of WHO Grade 3 (G3) Well-differentiated Neuroendocrine Tumor (WD-NET) and Poorly Differentiated Neuroendocrine Carcinoma (PD-NEC) of the Pancreas.
Tang LH; Basturk O; Sue JJ; Klimstra DS
Am J Surg Pathol; 2016 Sep; 40(9):1192-202. PubMed ID: 27259015
[TBL] [Abstract][Full Text] [Related]
34. Immunohistochemical analysis of the proliferative activity of neuroendocrine tumors from various organs. Are there indications for a neuroendocrine tumor-carcinoma sequence?
Helpap B; Köllermann J
Virchows Arch; 2001 Jan; 438(1):86-91. PubMed ID: 11213840
[TBL] [Abstract][Full Text] [Related]
35. UV Signature Mutations Reclassify Salivary High-grade Neuroendocrine Carcinomas as Occult Metastatic Cutaneous Merkel Cell Carcinomas.
Sun L; Cliften PF; Duncavage EJ; Lewis JS; Chernock RD
Am J Surg Pathol; 2019 May; 43(5):682-687. PubMed ID: 30986802
[TBL] [Abstract][Full Text] [Related]
36. Genomics of High-Grade Neuroendocrine Neoplasms: Well-Differentiated Neuroendocrine Tumor with High-Grade Features (G3 NET) and Neuroendocrine Carcinomas (NEC) of Various Anatomic Sites.
Uccella S; La Rosa S; Metovic J; Marchiori D; Scoazec JY; Volante M; Mete O; Papotti M
Endocr Pathol; 2021 Mar; 32(1):192-210. PubMed ID: 33433884
[TBL] [Abstract][Full Text] [Related]
37. Blood-based next-generation sequencing analysis of neuroendocrine neoplasms.
Zakka K; Nagy R; Drusbosky L; Akce M; Wu C; Alese OB; El-Rayes BF; Kasi PM; Mody K; Starr J; Shaib WL
Oncotarget; 2020 May; 11(19):1749-1757. PubMed ID: 32477464
[No Abstract] [Full Text] [Related]
38. Long Non-coding RNAs in Pulmonary Neuroendocrine Neoplasms.
Narayanan D; Mandal R; Hardin H; Chanana V; Schwalbe M; Rosenbaum J; Buehler D; Lloyd RV
Endocr Pathol; 2020 Sep; 31(3):254-263. PubMed ID: 32388776
[TBL] [Abstract][Full Text] [Related]
39. BRAF
Dizdar L; Werner TA; Drusenheimer JC; Möhlendick B; Raba K; Boeck I; Anlauf M; Schott M; Göring W; Esposito I; Stoecklein NH; Knoefel WT; Krieg A
Int J Cancer; 2019 Mar; 144(6):1379-1390. PubMed ID: 30144031
[TBL] [Abstract][Full Text] [Related]
40. Morphologic and Molecular Heterogeneity of Cervical Neuroendocrine Neoplasia: A Report of 14 Cases.
Ordulu Z; Mino-Kenudson M; Young RH; Van de Vijver K; Zannoni GF; Félix A; Burandt E; Wong A; Nardi V; Oliva E
Am J Surg Pathol; 2022 Dec; 46(12):1670-1681. PubMed ID: 36069807
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
